What are Therapeutic HIV vaccine drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic HIV vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting HIV envelope (Env) and Gag proteins). 0 are currently marketed, with 2 more in clinical development.

Therapeutic HIV vaccine

0 marketed 2 in Phase 3

This page covers all Therapeutic HIV vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV envelope (Env) and Gag proteins, gp120 (HIV-1 envelope glycoprotein).

Targets

HIV envelope (Env) and Gag proteins · gp120 (HIV-1 envelope glycoprotein)

Phase 3 pipeline (2)

Ad26.Mos4.HIV · Henry M. Jackson Foundation for the Advancement of Military Medicine · Immunology / Infectious Disease
Ad26.Mos4.HIV is a therapeutic HIV vaccine that uses an adenovirus vector to deliver mosaic HIV antigens, stimulating immune responses against diverse HIV strains.
MN rgp120/HIV-1 and A244 rgp120/HIV-1 · National Institute of Allergy and Infectious Diseases (NIAID) · Immunology / Infectious Disease
MN rgp120/HIV-1 and A244 rgp120/HIV-1 are recombinant HIV envelope protein vaccines designed to elicit immune responses against the gp120 surface antigen of HIV-1.

Patent intelligence

hiv vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates